GenuthS. Management of the adult onset diabetic with sulfonylurea drag failure. Endocrinol Metab Clin North Am1992; 21: 351–70.
4.
PughJARamirezGWagnerMLTuleyMSawyerJFriedbergSJ. Is combination sulfonylurea and insulin therapy useful in NIDDM patients?. Diabetes Care1992; 15: 953–9.
5.
ShankMLDel PratoSDeFronzoRA. Effective therapy for sulfonylurea failures in NIDDM. Diabetes1995; 44: 165–72.
6.
MelchiorWRJaberLA. Metformin: an antihyperglycemic agent for treatment of type II diabetes. Ann Pharmacother1996; 30: 158–64.
7.
StumvollMNurjhanNPerrielloGDaileyGGerichJE. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med1995; 333: 550–4.
8.
BaileyCJ. Metformin — an update. Gen Pharmacol1993; 24: 1299–309.
CampbellLKWhiteJRCampbellRK. Acarbose: review and assessment of its role in the treatment of diabetes mellitus. Ann Pharmacother1996; 30: 1255–62.
11.
LeonhardtWHanefeldMFischerSSchulzeJ. Efficacy of alpha-glucosidase inhibitors on lipids in NIDDM subjects with moderate hyperlipidaemia. Eur J Clin Invest1994; 24(suppl)3: 45–9.
12.
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med1993; 329: 977–86.
13.
BaileyCJ. Biguanides and NIDDM. Diabetes Care1992; 15: 755–72.
14.
BalfourJAMcTavishD. Acarbose — an update of its pharmacology and therapeutic use in diabetes mellitus. Drugs1993; 46: 1025–54.
15.
RobbinsDC. Acarbose — a new approach to the management of type II diabetes. Practical Diabetol1996; 15: 2–4, 6–8.
16.
TurnerRCullCHolmanR. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med1996; 124: 136–45.